The Therapeutic Goods Administration as part of the Australian Government Department of Health has published a number of documents as guidance on accessing medicinal cannabis for specific issues. See https://www.tga.gov.au/access-medicinal-cannabis-products-1 for general information.
Please see https://www.tga.gov.au/medicinal-cannabis-guidance-documents for more information.
- Multiple sclerosis – Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
- Palliative care – Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia
- Epilepsy – Guidance for the use of medicinal cannabis in the treatment of epilepsy in paediatric and young adult patients in Australia
- Nausea and vomiting – Guidance for the use of medicinal cannabis for the prevention or management of nausea and vomiting in Australia
- Pain – Guidance for the use of medicinal cannabis in the treatment of chronic non-cancer pain in Australia
